Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
49.50
+1.30 (2.70%)
Apr 23, 2025, 5:19 PM CET

STO:IBT.B Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-136.91-123.07-65.45-44.99-72.01
Upgrade
Other Amortization
0.820.820.820.820.82
Upgrade
Other Operating Activities
-5.442.07-33-18.8515.13
Upgrade
Change in Accounts Receivable
5.28-9.317.154.34-4.61
Upgrade
Change in Other Net Operating Assets
23.1228.274.693.062.29
Upgrade
Operating Cash Flow
-113.13-101.22-85.8-55.62-58.39
Upgrade
Other Investing Activities
---0.02--
Upgrade
Investing Cash Flow
---0.02--
Upgrade
Issuance of Common Stock
-101.04---
Upgrade
Other Financing Activities
2.01-4.521.90.091.76
Upgrade
Financing Cash Flow
2.0196.521.90.091.76
Upgrade
Foreign Exchange Rate Adjustments
5.45-2.073318.85-15.13
Upgrade
Miscellaneous Cash Flow Adjustments
-00-0--
Upgrade
Net Cash Flow
-105.68-6.78-50.91-36.69-71.75
Upgrade
Free Cash Flow
-113.13-101.22-85.8-55.62-58.39
Upgrade
Free Cash Flow Margin
-2828325.00%-131453.25%-714958.33%--
Upgrade
Free Cash Flow Per Share
-8.40-8.19-7.64-4.96-5.20
Upgrade
Cash Interest Paid
--0.290.410.3
Upgrade
Levered Free Cash Flow
-61.62-64.36-28.66-19.96-46.84
Upgrade
Unlevered Free Cash Flow
-61.62-64.36-28.47-19.71-46.65
Upgrade
Change in Net Working Capital
-28.4-18.96-11.84-7.42.32
Upgrade
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.